Ishlt wgreytag 4cp f4
ISHLT - ISHLTv Virtual Education: Segmental and Subsegmental Disease in CTEPH - Misconception and Missed Opportunities Enduring Material
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
After participating in this enduring material, how well are you able to:

Describe how to overcome a missed diganosis due to the difficulty in detecting disease at that level.

Utilize state of the art imaging to ensure that segmental and subsegmental disease is diagnosed and treated appropriately.

Explain the step-by-step approach to BPA to achieve and subsegmental disease.

Discuss the limitations in the management of distal disease.

Was the educational content scientifically sound and well researched?
If no, why not?
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What online content would you like ISHLT to present in the future?
How did you find out about this program?
What influenced you to participate in the ISHLT enduring material activity?
Webinar content:
The content was presented in a clear and logical manner.
The content presented is directly relevant to my practice.
Webinar format (scroll down for all questions):
The length of the webinar was appropriate.
The technology of the webinar platform was easy to navigate.
The Question and Answer portion added value to the webinar.
Demographic Information (scroll down for all questions):
Professional Speciality (click all that apply):
If you chose Other for your speciality, please enter it here:
Years of experience in transplantation:
Are you an ISHLT Member?
Are you with industry or a commercial organization such as pharmaceutical, medical devices, instruments, equipment?
Additional Comments:
Mr question
Provided by amedco